Is Opus Genetics, Inc. (IRD) a Buy, Sell, or Hold?
NASDAQ : IRD
Opus Genetics, Inc. — Institutional Ownership
$3.78 USD
$0.07 (1.89%)
- Volume
- 872.19K
- Average Volume
- 1.01M
- Market Capitalization
- $312.1M
- P/E Ratio
- -2.89
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $5.81
- Year Low
- $1.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.13
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-20 | Foundation Fighting Blindness, Inc. | 3.79M | 4.66% |
| 2026-05-20 | Foundation Fighting Blindness Retinal Degeneration Fund | 3.79M | 4.66% |
| 2026-05-15 | Nantahala Capital Management, LLC | 4.84M | 6.51% |
| 2026-05-15 | Balyasny Asset Management L.P. | 5.11M | 7.18% |
| 2026-05-15 | Caligan Partners LP | 6.08M | 8.50% |
| 2026-05-15 | Perceptive Advisors LLC | 8.83M | 9.99% |
| 2026-05-13 | AARON G.L. FLETCHER | 3.68M | 4.53% |
| 2026-05-13 | Adage Capital Management, L.P. | 6.03M | 8.47% |
| 2026-02-17 | Perceptive Advisors LLC | 7.17M | 9.99% |
| 2026-02-17 | Balyasny Asset Management L.P. | 5.11M | 7.41% |
| 2026-02-13 | Nantahala Capital Management, LLC | 7.12M | 9.99% |
| 2025-12-11 | Foundation Fighting Blindness Retinal Degeneration Fund | 5.49M | 8.00% |
| 2025-12-11 | Foundation Fighting Blindness, Inc. | 5.49M | 8.00% |
| 2025-08-14 | Nantahala Capital Management, LLC | 6.25M | 9.99% |
| 2025-08-11 | BIOS FUND III, LP | 430.66K | 0.70% |
| 2025-05-15 | Nantahala Capital Management, LLC | 4.7M | 9.99% |
| 2025-03-31 | Perceptive Advisors LLC | 4.51M | 9.99% |
| 2024-10-29 | Foundation Fighting Blindness Retinal Degeneration Fund | 2.56M | 8.16% |
| 2024-10-29 | Foundation Fighting Blindness, Inc. | 2.56M | 8.16% |
| 2022-05-17 | Richmond Brothers, Inc. | 1.12M | 5.84% |
| 2022-05-17 | Richmond Brothers 401(k) Profit Sharing Plan | 33448.0 | 1.00% |
| 2022-05-17 | David S. Richmond | 1.18M | 6.12% |
| 2022-05-17 | Matthew J. Curfman | 1.19M | 6.20% |
| 2022-05-17 | The RBI Opportunities Fund II, LLC | 274.98K | 1.43% |
| 2022-05-17 | RBI Private Investment III, LLC | 247.59K | 1.29% |
| 2022-05-17 | The RBI Opportunities Fund, LLC | 468.8K | 2.44% |
| 2022-02-14 | Altium Capital Management, LP | 2.68M | 4.99% |
| 2022-02-14 | Altium Growth Fund, LP | 2.68M | 4.99% |
| 2022-02-14 | Growth GP, LLC | 2.68M | 4.99% |
| 2022-02-14 | Mina Sooch | 1.29M | 6.70% |
| 2021-03-26 | Apexian Pharmaceuticals, Inc. | 779.99K | 7.14% |
| 2021-03-17 | Mina Sooch | 1.29M | 11.80% |
| 2021-02-16 | Altium Capital Management, LP | 314.82K | 9.99% |
| 2021-02-16 | Altium Growth GP, LLC | 314.82K | 9.99% |
| 2021-02-16 | Altium Growth Fund, LP | 314.82K | 9.99% |
| 2020-11-16 | RBI PI MANAGER, LLC | 364.9K | 5.10% |
| 2020-11-16 | Altium Capital Management, LP | 591.02K | 8.30% |
| 2020-11-16 | THE RBI OPPORTUNITIES FUND II, LLC | 78465.0 | 1.10% |
| 2020-11-16 | RBI PRIVATE INVESTMENT III, LLC | 54905.0 | 1.00% |
| 2020-11-16 | RICHMOND BROTHERS, INC. | 49492.0 | 1.00% |
| 2020-11-16 | Altium Growth Fund, LP | 591.02K | 8.30% |
| 2020-11-16 | Altium Growth GP, LLC | 591.02K | 8.30% |
| 2020-11-16 | THE RBI OPPORTUNITIES FUND, LLC | 231.53K | 3.30% |
| 2020-11-16 | MATTHEW J. CURFMAN | 49492.0 | 1.00% |
| 2020-11-16 | DAVID S. RICHMOND | 417.41K | 5.80% |
| 2020-11-12 | Empery Debt Opportunity Fund, LP | 537.82K | 7.58% |
| 2020-11-12 | Martin D. Hoe | 591.02K | 8.33% |
| 2020-11-12 | Ryan M. Lane | 591.02K | 8.33% |
| 2020-11-12 | Empery Asset Management, LP | 591.02K | 8.33% |
| 2018-10-29 | 13G | 1.92M | 5.10% |
| 2018-10-29 | 13G | 1.92M | 5.10% |
| 2018-10-29 | 13G | 1.92M | 5.10% |
| 2018-10-29 | 13G | 1.92M | 5.10% |
| 2018-10-29 | 13G | 1.92M | 5.10% |
| 2018-10-29 | 13G | 1.92M | 5.10% |
| 2018-10-26 | Heights Capital Management, Inc. | 1.92M | 5.10% |
| 2018-10-26 | CVI Investments, Inc. | 1.92M | 5.10% |
| 2017-01-17 | Ryan M. Lane | 12.5M | 4.99% |
| 2017-01-17 | Martin D. Hoe | 12.5M | 4.99% |
| 2016-01-19 | Martin D. Hoe | 500K | 7.36% |
| 2016-01-19 | Ryan M. Lane | 500K | 7.36% |
| 2015-11-10 | Ryan M. Lane | 500K | 8.44% |
| 2015-11-10 | Empery Asset Management, LP | 500K | 8.44% |
| 2015-11-10 | Martin D. Hoe | 500K | 8.44% |
| 2013-10-09 | Not Applicable | 9.71M | 7.24% |
| 2011-01-28 | Teva Pharmaceutical Industries Limited | 5.44M | 6.30% |
IRD Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2.01 | 622.22M | $1.25B | $45.09M | -$ | $1.21B |
| 2024-12-31 | $1.19 | 26.72M | $31.79M | $30.32M | -$ | $1.47M |
| 2023-12-31 | $1.29 | 21.59M | $27.85M | $50.5M | -$ | -$22.65M |
| 2022-12-31 | $1.29 | 19.93M | $25.71M | $42.63M | -$ | -$16.92M |
| 2021-12-31 | $1.29 | 14.85M | $19.16M | $24.53M | $538K | -$4.84M |
| 2020-12-31 | $1.29 | 4.66M | $6.01M | $16.4M | -$ | -$10.39M |
| 2019-12-31 | $1.29 | 7.09M | $9.15M | $1.54M | $5.67M | $13.28M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4.55 | 868.91M | $3.95B | $59.96M | $25.93M | $3.92B |
| 2025-12-31 | $2.01 | 622.22M | $1.25B | $45.09M | -$ | $1.21B |
| 2025-09-30 | $1.65 | 70.64M | $116.55M | $30.82M | $1.07M | $86.8M |
| 2025-06-30 | $0.94 | 63.38M | $59.71M | $32.43M | $1M | $28.28M |
| 2025-03-31 | $0.98 | 33.88M | $33.27M | $41.79M | -$ | -$8.52M |
| 2024-12-31 | $1.19 | 31.57M | $37.57M | $30.32M | -$ | $7.25M |
| 2024-09-30 | $1.31 | 26.15M | $34.25M | $36.63M | -$ | -$2.38M |
| 2024-06-30 | $1.29 | 25.83M | $33.32M | $41.41M | -$ | -$8.09M |
| 2024-03-31 | $1.29 | 24.52M | $31.63M | $47.16M | -$ | -$15.53M |
| 2023-12-31 | $1.29 | 21.52M | $27.76M | $50.5M | -$ | -$22.74M |
| 2023-09-30 | $1.29 | 21.45M | $27.67M | $42.35M | -$ | -$14.68M |
| 2023-06-30 | $1.29 | 20.96M | $27.04M | $39.98M | -$ | -$12.94M |